Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial (LoTam)
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of…
- Investigator
- Karen Daily
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
De-Escalation Breast Radiation for Hormone Sensitive HER-2 Negative Oncotype Recurrence (DEBRA)
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and…
- Investigator
- Tithi Biswas
- Status
- Accepting Candidates
- Ages
- 50 Years - 70 Years
- Sexes
- All
Magtrace and DCIS
The standard surgical approach for all patients undergoing mastectomy for the treatment of non-invasive, ductal carcinoma in situ (DCIS) is to perform axillary lymph node staging through use of a traditional sentinel lymph node biopsy (SLNB)…
- Investigator
- Jennifer Fieber
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All